Publicacións en colaboración con investigadores/as de University of Rome Tor Vergata (12)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  2. Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

    Journal of Osteopathic Medicine

2019

  1. Creating a Culture of Health in Planning and Implementing Innovative Strategies Addressing Non-communicable Chronic Diseases

    Frontiers in Sociology, Vol. 4

2016

  1. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062

2011

  1. European guidelines on the clinical management of HIV-1 tropism testing

    The Lancet Infectious Diseases, Vol. 11, Núm. 5, pp. 394-407

  2. European recommendations for the clinical use of HIV drug resistance testing: 2011 update

    AIDS Reviews, Vol. 13, Núm. 2, pp. 77-108

2009

  1. When and how to use maraviroc in HIV-infected patients

    AIDS, Vol. 23, Núm. 18, pp. 2377-2385

2008

  1. Optimal use of maraviroc in clinical practice

    AIDS, Vol. 22, Núm. 17, pp. 2231-2240

2006

  1. Introduction

    Journal of Acquired Immune Deficiency Syndromes

2004

  1. Updated European recommendations for the clinical use of HIV drug resistance testing

    Antiviral Therapy, Vol. 9, Núm. 6, pp. 829-848

2003

  1. Lamivudine resistance in human T-cell leukemia virus type 1 may be due to a polymorphism at codon 118 (V→i) of the reverse transcriptase (multiple letters)

    Antimicrobial Agents and Chemotherapy

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886